Skip to main content
. 2015 May 14;4(1):1–7. doi: 10.4102/ajlm.v4i1.158

TABLE 3.

Percent antibiotic resistance and MIC range of S. Kentucky, other Salmonella serotypes and ESBL-producing Salmonella isolates from poultry meat and faecal samples.

Class and antibiotics (μg/disc) E-test Disk diffusion: No. of samples demonstrating resistance (percentage of isolates resistant)
MIC Range μg/mL Salmonella Kentucky (n = 32)† Other Salmonella serotypes (n = 40) Salmonella ESBL-producers (n = 6) Total (n = 78)
Sulphonamides
Sulfamethoxazole (300 μg) NA 32 (100) 38 (95) 6 (100) 76 (97)
Trimethoprim/Sulphamethoxazole (1.25 μg/23.75 μg) 0.094 – >32 23 (72) 14 (35) 3 (50) 40 (51)
Tetracyclines
Tetracycline (30 μg) 2 – >256 31 (97) 38(95) 6(100) 75(96)
Quinolones
Naldixic acid (30 μg) 4 – >256 30 (94) 39 (98) 6 (100) 75 (96)
Penicillins
Ampicillin (10 μg) 24 – >256 31 (97) 22 (55) 6 (100) 59 (76)
β-lactamases
Ticarcillin/clavulanate (75/10 μg) NA 30 (94)‡ 17 (43)‡ 5 (83) 52 (67)
Ampicillin/sulbactam (10/10 μg) 3-256 11 (34) 12 (30) 2 (33) 25 (32)
Phenicols
Chloramphenicol (30 μg) NA 26 (81) 16 (40) 2 (33) 44 (56)
Fluoroquinolones
Ciprofloxacin (5 μg) 0.19–12 31 (97)‡ 1 (3)‡ 4 (66) 36 (46)
Aminoglycosides
Streptomycin (10 μg) 0.38–512 1 (3) 21 (53) 6 (100) 28 (36)
Gentamicin (10 μg) 0.38–24 9 (28) 13 (33) 3 (50) 24 (31)
Amikacin (30 μg) 1–2 1 (3) 0 0 1 (1)
Monobactam
Aztreonam (30 μg) NA 1 (3) 0 6 (100) 7 (9)
Cephems
Cefotaxime (30 μg) 24 – >256 1 (3) 1 (3) 6 (100) 8 (10)
Ceftriaxone (30 μg) 0.125 – >32 1 (3) 0 4 (66) 5 (6)
Ceftazidime (30 μg) 0.38 – >256 1 (3) 0 4 (66) 5 (6)
Cefepime (30 μg) 0.19–3 0 0 0 0
Carbapenems
Imipenem (10 μg) 0.038-0.125 0 0 0 0

†, 2 of the 34 Salmonella Kentucky isolates were ESBL-producers and are included in the Salmonella ESBL producers column.

‡, Significant difference in resistance level found between S. Kentucky and other Salmonella serotypes were calculated at p < 0.01.

MIC, minimum inhibitory concentration; ESBL, extended-spectrum β-lactamases.